Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Prospective, Pilot Study to Evaluate the Efficacy and Safety of Best Physician's Choice of Standard of Care Combined With NaviFUS System in Patients With Recurrent Glioblastoma Multiforme

NCT04446416 is registered in ClinicalTrials.gov with NaviFUS Corporation as lead sponsor.

NCT NCT04446416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04446416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Prospective, Pilot Study to Evaluate the Efficacy and Safety of Best Physician's Choice of Standard of Care Combined With NaviFUS System in Patients With Recurrent Glioblastoma Multiforme
Lead sponsor
NaviFUS Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 21, 2020
Completion date
August 4, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, glioblastoma, glioblastoma multiforme, glioma, neoplasms, neoplasms, nerve tissue